Literature DB >> 26909241

High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.

Laimas Jonaitis1, Gediminas Kiudelis1, Paulius Slepavicius1, Limas Kupcinskas1.   

Abstract

AIM: To evaluate the frequency of Helicobacter pylori (H. pylori) reinfection in peptic ulcer patients during 9 years after H. pylori eradication.
METHODS: We invited 117 peptic ulcer patients in whom eradication of H. pylori was confirmed 1 year after eradication treatment both by histology and by rapid urease test. In total, 57 patients were available for the study procedures: 34 (59.6%) male, 23 (40.4%) female; mean age 52.3 ± 13.0 years. There were 45 (78.9%) patients with duodenal ulcer and 12 (21.1%) with gastric ulcer. H. pylori was diagnosed by a rapid urease test and histology if endoscopy was performed. If endoscopy was refused, H. pylori was diagnosed by the C14-urea breath test and serology. H. pylori was established if at least one of the tests was positive.
RESULTS: The mean follow-up was 8.9 ± 1.0 years (range, 6-12). H. pylori was established in 15 patients. In 2 H. pylori-negative patients, H. pylori was established during the follow-up period and eradicated. Therefore, we consider that reinfection occurred in 17 patients. In the per protocol analysis, reinfection was established in 17 of 57 (29.8%; 95%CI: 19.2-42.2) patients during the follow-up period. The annual rate of infection was 3.36%. If all non-responders were considered H. pylori-negative, reinfection would be 14.5% (17/117), the annual rate being 1.63%. The mean age of patients with reinfection was 51.8 ± 14.0 years, and without reinfection was 52.5 ± 13.0 years, P > 0.05; the mean body mass index of patients with reinfection was 27.2 ± 4.1 kg/m(2), and without reinfection was 25.7 ± 4.2 kg/m(2), P > 0.05. There were no differences in the reinfection rates according the location of the peptic ulcer, the eradication regimen used, and smoking status.
CONCLUSION: The reinfection rate of H. pylori is relatively high in Lithuania and probably related to the high prevalence of H. pylori, what may reflect differences in the socioeconomic status between Western and Eastern European countries.

Entities:  

Keywords:  Eradication; Helicobacter pylori; Peptic ulcer; Prevalence; Reinfection

Year:  2016        PMID: 26909241      PMCID: PMC4753185          DOI: 10.4291/wjgp.v7.i1.181

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  29 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

Review 2.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 3.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

4.  Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up.

Authors:  Fernando M Silva; Tomas Navarro-Rodriguez; Ricardo C Barbuti; Rejane Mattar; Claudio L Hashimoto; Jaime N Eisig
Journal:  Helicobacter       Date:  2010-02       Impact factor: 5.753

5.  Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

Authors:  K Ming Fock; Peter Katelaris; Kentaro Sugano; Tiing Leong Ang; Richard Hunt; Nicholas J Talley; Shiu Kum Lam; Shu-Dong Xiao; Huck Joo Tan; Chun-Ying Wu; Hyun Chae Jung; Bui Huu Hoang; Udom Kachintorn; Khean-Lee Goh; Tsutomu Chiba; Abdul Aziz Rani
Journal:  J Gastroenterol Hepatol       Date:  2009-10       Impact factor: 4.029

6.  Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.

Authors:  Limas Kupcinskas; Lone Rasmussen; Laimas Jonaitis; Gediminas Kiudelis; Marianne Jørgensen; Neringa Urbonaviciene; Vytas Tamosiunas; Juozas Kupcinskas; Jolanta Miciuleviciene; Edmundas Kadusevicius; Douglas Berg; Leif P Andersen
Journal:  APMIS       Date:  2012-10-19       Impact factor: 3.205

7.  Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

Authors:  Lorenzo Fuccio; Rocco Maurizio Zagari; Leonardo Henry Eusebi; Liboria Laterza; Vincenzo Cennamo; Liza Ceroni; Diego Grilli; Franco Bazzoli
Journal:  Ann Intern Med       Date:  2009-07-21       Impact factor: 25.391

Review 8.  Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications.

Authors:  Y-Y Zhang; H H-X Xia; Z-H Zhuang; J Zhong
Journal:  Aliment Pharmacol Ther       Date:  2008-10-20       Impact factor: 8.171

9.  A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.

Authors:  Limas Kupcinskas; Laimas Jonaitis; Gediminas Kiudelis
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 2.566

10.  Could the simplified (14)C urea breath test be a new standard in noninvasive diagnosis of Helicobacter pylori infection?

Authors:  Elif Ozdemir; Neşe I Karabacak; Bülent Degertekin; Meltem Cirak; Ayşe Dursun; Doruk Engin; Selahattin Unal; Mustafa Unlü
Journal:  Ann Nucl Med       Date:  2008-08-29       Impact factor: 2.668

View more
  5 in total

Review 1.  Are the view of Helicobacter pylori colonized in the oral cavity an illusion?

Authors:  J K C Yee
Journal:  Exp Mol Med       Date:  2017-11-24       Impact factor: 8.718

Review 2.  Significance of dormant forms of Helicobacter pylori in ulcerogenesis.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Magomedalievna Reshetnyak
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

Review 3.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

4.  Low Re-infection Rate of Helicobacter pylori after Successful Eradication in Thailand: A 2 Years Study

Authors:  Ratha Korn Vilaichone; Arti Wongcha Um; Peranart Chotivitayatarakorn
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

5.  Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Authors:  Paulius Jonaitis; Juozas Kupcinskas; Olga P Nyssen; Ignasi Puig; Javier P Gisbert; Laimas Jonaitis
Journal:  Medicina (Kaunas)       Date:  2021-06-23       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.